Diagnostic Usefulness of p53 Immunostaining in Gastric Cancer and Dysplasia: A Real-world Clinical Experience
In Vivo · 2024
DOI: 10.21873/invivo.13641 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Vivo, 2024. Verfasst von Ji Hyun Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Stomach Neoplasms, Tumor Suppressor Protein p53, Immunohistochemistry, Biomarkers, Tumor. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Yonsei University College of Medicine, Seoul, Republic of Korea.
- Department of Pathology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea san0729@naver.com.
- Department of Pathology, School of Medicine, Kyungpook National University, Daegu, Republic of Korea teiroa83@knu.ac.kr.
Zitieren
APA
Park, J. H., Seo, A. N., & Kim, M. (2024). Diagnostic Usefulness of p53 Immunostaining in Gastric Cancer and Dysplasia: A Real-world Clinical Experience. In Vivo. https://doi.org/10.21873/invivo.13641
Vancouver
Park JH, Seo AN, Kim M. Diagnostic Usefulness of p53 Immunostaining in Gastric Cancer and Dysplasia: A Real-world Clinical Experience. In Vivo. 2024. doi:10.21873/invivo.13641
BibTeX
@article{Park2024,
author = {Park, Ji Hyun and Seo, An Na and Kim, Moonsik},
title = {Diagnostic Usefulness of p53 Immunostaining in Gastric Cancer and Dysplasia: A Real-world Clinical Experience},
journal = {In Vivo},
year = {2024},
doi = {10.21873/invivo.13641}
}
EUVIMED